Hologic Announces Financial Results for Second Quarter Fiscal 2015
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/22/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- One killed, three injured when man attacks Swedish school with sword
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
Hologic (HOLX) PT Boosted to $37 at Leerink Partners Amid 'Strong' Q2
April 30, 2015 6:33 AM EDTLeerink Partners analyst Richard Newitter reiterated an Outperform rating and boosted his price target on Hologic (NASDAQ: HOLX) to $37.00 (from $34.00) following "strong" Q2 results.
commented, "HOLX delivered a strong F2Q led by solid tomo sales (now ~1800 placements in US) and strength in... More
Hologic (HOLX) Tops Q2 EPS by 2c, Raises FY15 Guidance
April 29, 2015 5:04 PM EDTHologic (NASDAQ: HOLX) reported Q2 EPS of $0.41, $0.02 better than the analyst estimate of $0.39. Revenue for the quarter came in at $655.5 million versus the consensus estimate of $646.49 million.
Hologic sees FY2015 EPS of $1.57-$1.59, versus prior guidance of $1.54-$1.57 and the consensus of $1.57. Hologic... More
